Medicare Copays For New Alzheimer's Drug Could Reach $11,500 Annually Some advisors to the Food and Drug Administration have quit over ...
Medicare Copays For New Alzheimer's Drug Could Reach $11,500 Annually
Some advisors to the Food and Drug Administration have quit over the drug which critics say has questionable benefits. The FDA said it can reduce clumps of plaque in the brain and may slow dementia.
Read more on NPR
Some advisors to the Food and Drug Administration have quit over the drug which critics say has questionable benefits. The FDA said it can reduce clumps of plaque in the brain and may slow dementia.
Read more on NPR
